DEF 14A

Company

Pharma-Bio Serv, Inc.

Filed

April 8, 2024

Period of Report

April 4, 2024

Accession Number

0001654954-24-004363

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →